mRNA-Based Therapeutics in Cancer Treatment
Over the past two decades, significant technological innovations have led to messenger RNA (mRNA) becoming a promising option for developing prophylactic and therapeutic vaccines, protein replacement therapies, and genome engineering. The success of the two COVID-19 mRNA vaccines has sparked new ent...
Saved in:
Main Authors: | Han Sun (Author), Yu Zhang (Author), Ge Wang (Author), Wen Yang (Author), Yingjie Xu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
by: De‐feng Li, et al.
Published: (2023) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022) -
Chemically modified in-vitro-transcribed mRNA encoding thrombopoietin stimulates thrombopoiesis in mice
by: Yu Zhang, et al.
Published: (2022) -
The potential of mRNA vaccine in HCC treatment
by: Rui Han
Published: (2023) -
Translational kinetic‐pharmacodynamics of mRNA‐6231, an investigational mRNA therapeutic encoding mutein interleukin‐2
by: Ivana Liric Rajlic, et al.
Published: (2024)